CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 424B5 Offering Prospectus
- 4 Option exercise General Counsel and Secretary acquired 22,026 shares (option exercise)
- 4 Open-market sale Director sold 171,004 shares at an average $154.53 ($26,424,505)
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
- 4 Open-market sale President sold 100,000 shares at $125.00 ($12,500,000)
- 8-K Event Regulation FD disclosure · Other events
- 4 Other disposition Director disposed of 518,519 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale President sold 25,000 shares at $100.00 ($2,500,000)
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 414,816 shares (other)
- 4 Open-market sale Director sold 3,035 shares at $86.87 ($263,636)
Page 23 of 45 · 883 filings